Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Prostatic Neoplasms”
Phase 3 3
- CTT1057NOVARTIS AGProstatic Neoplasms
- Ifinatamab deruxtecanMerck & Co., Inc.Prostatic Neoplasms
- OpevesostatMerck & Co., Inc.Prostatic Neoplasms
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.